Form 8-K - Current report:
SEC Accession No. 0001193125-24-223676
Filing Date
2024-09-23
Accepted
2024-09-23 16:15:31
Documents
13
Period of Report
2024-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d834306d8k.htm   iXBRL 8-K 28350
  Complete submission text file 0001193125-24-223676.txt   155689

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA spry-20240917.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE spry-20240917_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spry-20240917_pre.xml EX-101.PRE 11706
15 EXTRACTED XBRL INSTANCE DOCUMENT d834306d8k_htm.xml XML 3773
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 241316408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)